VASCULAR THERAPIES INC

Profile

Company Names

VASCULAR THERAPIES INC
VASCULAR THERAPIES LLC

Addresses

105 UNION AVENUE, CRESSKILL, NJ 07626

105 CRESSKILL AVENUE, NEW JERSEY, NJ 07626

105 CRESSKILL AVENUE, CRESSKILL, NJ 07626

181 EAST 90TH ST, SUITE 12B, NEW YORK, NY 10128

Phone Numbers

201-266-8310
212-266-8310
212-410-3632

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$89,178,545.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2022-02-18 
$23,963,442.00 
$25,213,472.00 
$1,250,030.00 
Equity 
9
2021-08-13 
$3,748,712.00 
$4,000,000.00 
$251,288.00 
Debt 
8
2019-11-08 
$7,382,500.00 
$14,765,000.00 
$7,382,500.00 
Debt 
7
2018-10-01 
$12,360,000.00 
$21,100,000.00 
$8,740,000.00 
Equity 
6
2015-02-12 
$31,000,000.00 
$31,000,000.00 
$0.00 
Equity 
5
2012-06-28 
$5,195,226.00 
$14,999,994.00 
$9,804,768.00 
Equity 
4
2011-05-27 
$3,159,325.00 
$5,000,000.00 
$1,840,675.00 
Equity 
3
2010-08-04 
$646,340.00 
$646,340.00 
$0.00 
Debt 
2
2010-01-07 
$348,000.00 
$348,000.00 
$0.00 
Debt 
1
2009-02-05 
$1,375,000.00 
$1,375,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BAMBERGER 
DIRECTOR
VASCULAR THERAPIES LLC   |  VASCULAR THERAPIES INC   |  ACCESS HEALTHNET HOLDINGS, INC.   |  TETRA INSIGHTS, INC.
PAUL 
 
BARKOFSKY 
DIRECTOR, EXECUTIVE OFFICER
VASCULAR THERAPIES LLC
ROBERT 
 
CROCE 
DIRECTOR
ARSTASIS INC   |  SVELTE MEDICAL SYSTEMS INC   |  VASCULAR THERAPIES LLC   |  EXPLORAMED IV, L.L.C.   |  NEOTRACT INC   |  VIBRYNT, INC   |  VASCULAR THERAPIES INC   |  EXPLORAMED NC7, INC.   |  EARLENS CORP
GERALD 
 
DORROS 
DIRECTOR
VASCULAR IMAGING CORP   |  VASCULAR THERAPIES LLC   |  WINDMILL CARDIOVASCULAR SYSTEMS INC   |  VASCULAR THERAPIES INC   |  MICRO INTERVENTIONAL DEVICES, INC.
ROBERT 
 
FLANAGAN 
DIRECTOR
SAGENT HOLDING CO.   |  SVELTE MEDICAL SYSTEMS INC   |  SNAGFILMS, INC.   |  VASCULAR THERAPIES INC   |  VERAX BIOMEDICAL INC
SRIRAM 
 
IYER 
EXECUTIVE OFFICER, DIRECTOR
VASCULAR THERAPIES LLC   |  VASCULAR THERAPIES INC   |  RT ONCOLOGY SERVICES CORP
SAMUEL 
M. 
LIANG 
DIRECTOR
VASCULAR THERAPIES LLC
JOHN 
 
MCDERMOTT 
EXECUTIVE OFFICER, DIRECTOR
ABQID FUND I, L.P.   |  ITHERAPYDOCS, INC.   |  ENDOLOGIX INC /DE/   |  VASCULAR THERAPIES INC   |  LEGACY MUSIC PARTNERS LLC   |  PARAGONIX TECHNOLOGIES, INC.
ANDREW 
 
MIDLER 
DIRECTOR
CELL MDX, LLC   |  CURASEAL INC.   |  BIOIQ, INC.   |  ASEKO INC.   |  ANCORA HEART, INC.   |  VASCULAR THERAPIES INC   |  FIDELIS PHARMACEUTICALS, INC.   |  ASEKO, INC.   |  FIDELIS ANIMAL HEALTH INC.
DAN 
 
RYAN 
DIRECTOR
BYTELIGHT, INC.   |  WATERMARK MEDICAL HOLDINGS, INC.   |  VASCULAR THERAPIES INC   |  BIG POPPY HOLDINGS, INC.   |  REDDYPORT, INC.   |  BSP CLO EQUITY FUND III L.P.
DANIEL 
 
RYAN 
DIRECTOR
LOGICSTREAM HEALTH, INC.   |  VASCULAR THERAPIES INC   |  CIBO TECHNOLOGIES, INC.   |  ARE-MA REGION NO. 107 REIT, LLC
SOMU 
 
SUBRAMANIAM 
DIRECTOR
BIOVEX GROUP, INC.   |  ACHRONIX SEMICONDUCTOR CORP   |  RF ARRAYS INC   |  LIGHTWIRE INC   |  RESOLVE THERAPEUTICS LLC   |  DALI SYSTEMS CO. LTD.   |  TRELLIS BIOSCIENCE LLC   |  BIOSCALE INC   |  SILICON SPACE TECHNOLOGY CORP   |  JUVENTAS THERAPEUTICS INC   |  DIRECTED SENSING INC.   |  PRIVATE GROUP NETWORKS, INC.   |  PERCEPTIMED, INC.   |  SVELTE MEDICAL SYSTEMS INC   |  ALEXAR THERAPEUTICS, INC.   |  NEW SCIENCE VENTURES FUND III, L.P.   |  NEW SCIENCE VENTURES FUND III (OFFSHORE), L.P.   |  VASCULAR THERAPIES INC   |  NSV 2016 OPPORTUNITIES FUND, L.P.   |  NSV 2016 OPPORTUNITIES FUND (OFFSHORE), L.P.   |  NSV 2017 OPPORTUNITIES FUND, L.P.   |  RALEXAR THERAPEUTICS, INC.   |  NSV 2018 NEW HORIZONS FUND, L.P.   |  NSV 2018 OPPORTUNITIES FUND, L.P.   |  NSV 2020 PREFERRED LP FUND, L.P.   |  NSV GROWTH OPPORTUNITIES FUND, L.P.   |  NSV 2021 GROWTH OPPORTUNITIES FUND, L.P.   |  PHASE FOUR, INC.   |  PAKAL TECHNOLOGIES, INC.   |  BRIGHTVOLT, INC   |  ABL SPACE SYSTEMS CO   |  GLYDWAYS, INC.   |  FERRIC, INC.
SOMUS 
 
SUBRAMANIAM 
DIRECTOR
VASCULAR THERAPIES INC
KIYOSHI 
 
TAKESUE 
DIRECTOR
VASCULAR THERAPIES INC
ALLAN 
 
TESSLER 
DIRECTOR
VASCULAR THERAPIES INC   |  XO HEALTH INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-18 
2021-08-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-08-13 
2019-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-11-08 
2018-10-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-01 
2016-12-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-12 
2015-02-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-12 
2013-07-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-28 
2012-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-28 
2011-06-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-27 
2011-04-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-01-07 
2011-04-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-08-04 
2011-04-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-02-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROBERTS MITANI, LLC
30022